Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

R2 v. ISSI

This article was originally published in The Gray Sheet

Executive Summary

Intellectual property suit charges Intelligent Systems Software, Inc. with infringing three patents covering the ways in which R2 devices scan, process and display images. PMA-approved by FDA in 1998 for use with film-based screening mammography to assist radiologists in minimizing false readings, R2's ImageChecker received an expanded indication for diagnostic mammograms in 2001. In April, the agency approved R2 CAD technology for use with the GE Senographe full-field digital mammography system. ISSI's MammoReader was PMA-approved for "identifying areas on the original mammogram that may warrant a second review" in January, preceding film digitizer Howtek's acquisition of the firm in February (1"The Gray Sheet" Feb. 25, 2002, p. 8)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016699

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel